TMO250110P545000
- 4.23
- 0.000.00%
Thermo Fisher Scientific Newsroom
Human Embryonic Stem Cells Industry to Generate Revenues of $6.76 Billion by 2035, up From $2.26 Billion 2024 - Thermo Fisher Scientific, STEMCELL Technologies, and Astellas Pharma Dominate the Landscape
NVIDIA open-sources the world's foundational models, humanoid robots accelerate towards the 'ChatGPT moment'.
① Recently, NVIDIA launched the physical AI model Cosmos, which is capable of predicting environments such as warehouses and road conditions to train Siasun Robot&Automation; ② According to NVIDIA's disclosed list, the first batch of users for Cosmos includes manufacturers such as 1X, Agility, Figure AI, and Xiaopeng Autos; ③ Brokerages believe that in the collection methods of training data for humanoid robots, synthetic data will greatly promote the development of robots.
We Think Thermo Fisher Scientific (NYSE:TMO) Can Stay On Top Of Its Debt
Argus Adjusts Thermo Fisher Scientific's Price Target to $620 From $665
Thermo Fisher Scientific Hits 7-week High
Bernstein Maintains Thermo Fisher Scientific(TMO.US) With Hold Rating
Bernstein Sticks to Its Hold Rating for Thermo Fisher (TMO)
Market Volatility Is Back. Here's How to Play It. -- Barrons.com
United States Chromatography Resin Market Competition, Forecast and Opportunities, 2029F Featuring Key Players, GE Healthcare, Merck, Thermo Fisher Scientific, Pall, and Purolite
Thermo Fisher Scientific to Present at 43rd Annual J.P. Morgan Healthcare Conference on January 14, 2025
Press Release: Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, January 30, 2025
Express News | Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, January 30, 2025
Bioconjugation Market Global Forecast to 2029 With Danaher, Lonza, Thermo Fisher Scientific, Merck, AbbVie, WuXi Biologics, and Sartorius Leading
After experiencing a bumper harvest in 2024, the USA ETF may encounter setbacks this year.
The USA Exchange Traded Fund (ETF) received a record inflow of $1.1 trillion in 2024, but entering 2025, rapid growth may face more obstacles.
Evercore Maintains Thermo Fisher Scientific(TMO.US) With Buy Rating, Cuts Target Price to $585
Is Thermo Fisher Scientific (NYSE:TMO) the Best Low Volatility Stock to Buy Right Now?
Here's How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 20 Years
Is Thermo Fisher Scientific Inc. (TMO) the Best Stock for 10 Years?
Jim Cramer on Thermo Fisher Scientific Inc. (TMO): 'I Think Things Will Gradually Improve For Thermo Fisher With Business Picking Up In 2025 and 2026'
How Humanoid Robots and AI Will Change the Workforce